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Severe combined immune defi ciency (SCID) is a group of genetic disorder 
associated with development of T- and/or B-lymphocytes. Recombination-activat-
ing genes (RAG1/2) play a critical role on VDJ recombination process that leads to 
the production of a broad T-cell receptor (TCR) and B-cell receptor (BCR) repertoire 
in the development of T and B cells. RAG1/2 genes mutations result in various forms 
of primary immunodefi ciency, ranging from classic SCID to Omenn syndrome (OS) 
to atypical SCID with such as granuloma formation and autoimmunity. Herein, we 
reported 4 patients with RAG1 defi ciency: classic SCID was seen in two patients 
who presented with recurrent pneumonia and chronic diarrhoea, and failure to 
thrive. OS was observed in one patient who presented with chronic diarrhoea, skin 
rash, recurrent lower respiratory infections, and atypical SCID was seen in one pa-
tient who presented with Pyoderma gangrenosum (PG) and had novel RAG1 muta-
tion.
Keywords: atypical SCID, classic SCID, Omenn syndrome, RAG1 mutation
Introduction
Recombination-activating genes (RAG1/2) effect on the VDJ (variable, di-
versity, and joining) recombination which leads to the generation of diverse anti-
gen receptors [1]. A complete lack of RAG activity causes classic SCID manifes-
tations with the absence of mature T and B cells, but the presence of natural 
killer (NK) cells (T−B−NK+SCID) [2]. On the other hand, the spectrum of dis-
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ease has expanded to OS to atypical SCID with early onset autoimmunity, cyto-
megalovirus (CMV) infection with γδ T-cell expansion, granuloma formation, 
and isolated CD4+ lymphopenia [3–8]. The different clinic spectrums of RAG 
defi ciency are partially explained by different residual RAG activity. Although 
null mutations lead to classic SCID phenotype, hypomorphic mutations cause 
more variable clinic presentations [3, 9]. Herein, we reported 4 patients with 
RAG1 defi ciency with different clinical phenotypes from SCID to OS to atypical 
SCID.
Cases
Patient #1
He was a 5-month-old boy. The patient was born after a normal pregnancy 
and delivery as the fi rst child of second degree consanguineous parents. At the 
age of 20 days, he suffered from wheezing and hospitalized as bronchiolitis. His 
symptoms resolved with bronchodilators within 10 days. His respiratory symp-
toms repeated a few days later and he was interned again because of severe pneu-
monia for two months. Subsequently the patient was transferred to the Depart-
ment Pediatric Immunology at the age of 3 months. Physical examination revealed 
failure to thrive, 3–4 cm hepatosplenomegaly below the costal margins, and bi-
lateral crackles. Chest radiographs revealed pneumonia without thymus shadow. 
Laboratory fi ndings at the time of admission were as follows; absolute neutrophil 
count (ANC): 3370/mm3, absolute lymphocytes count (ALC): 440/mm3, IgG: 298 
mg/dL (345–1,236 mg/dL), IgM: 16 mg/dL (41–173 mg/dL), and IgA: 6.1 mg/dL 
(14–159 mg/dL). Flow cytometric analysis of the lymphocyte subsets revealed: 
CD3 T cells: 37/mm3 (2400–8100), CD4 T cells:  5/mm3 (1400–5200), CD8 T 
cells: 33/mm3 (600–300), CD19 B cells: 80 /mm3 (300–1400), CD16/CD56 (NK) 
cells: 320/mm3 (200–1800). The clinical and laboratory fi ndings were consistent 
with T-B-NK+ SCID. A homozygous missense mutation (c.1229G>A, p.Arg-
410Gln) was detected in the RAG1 gene (Tables I and II). Haploidentical haema-
topoietic stem cell transplantation (HSCT) was performed from the mother. 
But he died from the progression of respiratory infection at +110 days after trans-
plantation.
Patient #2
A 7-month-old girl was transferred to the Department of Pediatric Immu-
nology with complaints of recurrent thrush, chronic diarrhea, and anal fi ssure at 
the age of 2 months. She was born as second child of non-consanguineous par-
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ents with weight of 3.2 kg at term. Physical examination revealed thrush and 
failure to thrive. No thymus shadow was observed on chest radiography. Labora-
tory investigations revealed; ALC: 630/mm3, IgG: 210 mg/dL (345–1236 mg/dL), 
IgM: 17.1 mg/dL (41–173 mg/dL), IgA: 6.4 mg/dL (14–159 mg/dL), CD3 T cells: 
30/mm3 (2400–8100), CD4 T cells: 22/mm3 (1400–5200), CD8 T cells: 8/mm3 
(600–300), CD19 B cells: 80 /mm3 (300–1400), and NK cells: 500/mm3 (200–
1800). Her condition was consistent with T-B-NK+ SCID. Diagnosis of SCID 
was confi rmed by genetic analysis of the RAG1 gene; a homozygous nonsense 
mutation (c.1767C>G, p.Tyr589Stp) was detected (Tables I and II). Intravenous 
immunoglobulin (IVIG) replacement and antimicrobial prophylaxis with co- 
trimaxozole and itraconazole were initiated. HSCT was planned to the patient. 
Unfortunately she died due to pneumonia while unrelated donor screening at the 
age of 9 months.
Patient #3
A 1.5-year-old girl was born as the second child of second degree consan-
guineous parents. She was referred to the Department of Pediatric Emergency 
with prolonged fever, cough, vomiting, chronic diarrhoea, and skin lesions at the 
age of 5 months. Physical examination revealed failure to thrive, 3–4 cm hepato-
splenomegaly below the costal margins, axillary and inguinal multiple lymphad-
enopathies, bilateral crackles, and maculopapular rash on the trunk (Fig. 1a). 
Chest radiography revealed bilateral infi ltrations which were consistent with se-
vere pneumonia. Laboratory evaluation revealed ALC: 1770/mm3, eosinophil: 
19.5% (770/mm3), IgG: 134 mg/dl (345–1,236 mg/dl), IgM: 17 mg/dl (41–173 mg/dl), 
Ig: 6.3 mg/dl (14–159 mg/dl), IgE: 1950 iu/ml (0–200 iu/ml), CD3 T cells: 920/mm3 
(2400–8100), CD4 T cells: 710/mm3 (1400–5200), CD8 T cells: 210/mm3(600–
300), CD19 B cells: 10/mm3 (300–1400), and NK cells: 830/mm3 (200–1800). Her 
clinical and immunologic evaluation was consistent with a T-B-NK+SCID (OS). 
Flow cytometric analysis of the precursor B-cell compartment in bone marrow 
showed a complete block in precursor B cell differentiation. A RAG defi ciency 
was suspected, and direct fl uorescent sequencing of the RAG1 gene revealed only 
a heterozygous mutation (c.2209C>T, p.Arg737Cys). The second mutation in the 
RAG-1, RAG2, Artemis, and ADA genes were not found (Tables I and II). Hap-
loidentical HSCT was performed at 1 year old from the father. The patient is well 
now (Fig. 1b).
Patient #4
A 16-year-old girl was born as the fi rst child of second consanguineous 
parents at term. In her fi rst years of life she just had aphthous stomatitis, as some-
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times found in healthy children. At the age of 8 years, splenomegaly was ob-
served and she was referred to the Department of Pediatric Immunology. Physical 
examination revealed splenomegaly. Immunologic evaluation revealed pancyto-
penia with ANC: 480/mm3, ALC: 940/mm3, hypergammaglobulinemia with 
IgG: 2900 mg/dL (527–1590), IgA: 903mg/dL (36–268), IgM: 71 mg/dL (30–220), 
IgE: 50 iu/ml (0–200), diminished number of lymphocytes subsets with CD3 
cells: 766/mm3 (1000–4900), CD4 cells: 432/mm3 (500–2700), CD8 cells: 376/mm3 
Figure 1. Omenn syndrome, (a) at the diagnosis time, (b) after the HSCT in patient #3
Figure 2. Pyoderma gangrenosum, (a) before the treatment, (b) after the treatment in patient #4
1a 1b
2a 2b
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(300–2100), CD19 cells: 60/mm3 (200–2200), NK cells: 80/mm3 (200–900), and 
direct Coombs positive result. At fi rst, because of splenomegaly, hypergamma-
globulinemia, pancytopenia, positive double negative T cells (5.5%) and positive 
autoantibodies the patient was thought to have autoimmune lymphoproliferative 
syndrome. At the age of 14 years, she experienced PG on her left ankle after an 
insect bite while on holiday (Fig. 2a). PG healed completely with different treat-
ment over two years (Fig. 2b). Genetic analysis indicated that she has a novel 
homozygous mutation at cDNA position 2290 (c.2290C>T, p.Arg764Cys) in exon 
2 of the RAG1 gene (Tables I and II) [10].
Discussion
RAG1/2 genes are specifi cally expressed in immature T and B cells [11]. 
Mutations in the RAG1/2 genes can lead to null protein activity or hypomorphic 
protein activity depending on severity of the mutations. Although null mutations 
of RAG1/2 genes lead to classic T-B-NK+ SCID phenotype, hypomorphic muta-
tions of these genes often result in OS and atypical SCID [12]. Mutations in 
RAG1/2 genes are responsible almost 10% of all SCID cases and usually these 
mutations result in classic T-B-NK+SCID. Mutations in the RAG1/2 genes ac-
count for approximately 70% etiology of T-B-NK+SCID [13–14]. Two patients 
fulfi lled clinical criteria of classic T-B-NK+SCID in the presented study. Haploi-
dentical HSCT underwent one of them. Unfortunately, he died due to progression 
of respiratory infection at +110 days after transplantation. Second classic SCID 
patient also died at the age of 9 months while unrelated donor screening. Hypo-
morphic mutations in the RAG1/2 genes have been associated with different 
clinical and immunologic phenotypes that include OS and atypical SCID [15]. 
OS presents erythroderma, eosinophilia, lymphadenopathy, and increased serum 
IgE levels as presented in patient #3. In medical literature, it has been reported 
two adult onset immunodefi ciency caused by heterozygous mutations in RAG1 
and adenosine deaminase defi ciency (ADA) [16–17] as in patient #3. Abraham et 
al. [16] reported a patient presented with chronic dermatitis, pruritus, and hyper-
keratosis. In that patient, the clinical and immunologic examination showed 
 eosinophilia, elevated IgE (747 kU/L), profound pan-T-cell lymphopenia results 
from heterozygous RAG1 mutation as in our patient #3. Another patient with 
adult onset immunodefi ciency caused by heterozygote ADA defi ciency was re-
ported by Shovlin et al. [17]. Additional to these articles reported by Abraham et 
al. [16] and Shovlin et al. [17], Pico-Knijnenburg et al. [18] reported three siblings 
who had recurrent infections, generalized rashes, malnutrition and chronic diar-
rhoea. In those siblings, there were extremely low T and B cells. Also, there was 
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a complete block in precursor B cell differentiation in bone marrow as in the 
presented patient #3. In those siblings, initially a heterozygous mutation in RAG1 
gene was identifi ed and subsequently second mutation was found with further 
investigations and they said that in the event of heterozygous mutations of RAG1 
gene to detect other second defect further investigations are required [18]. In the 
presented patient #3, as in those siblings reported by Pico-Knijnenburg et al. [18], 
only a heterozygous mutation in RAG1 gene. The second mutation in the RAG1, 
RAG2, Artemis, and ADA genes were not found with sequencing. Maybe we 
need further investigations to detect second mutation in the presented patient #3 
as said Pico-Knijnenburg et al. [18]. Atypical SCID result from RAG genes muta-
tions shows varying numbers of T and B cells and varied clinic manifestations 
such combined immune defi ciency with granuloma and/or autoimmunity, γδ 
T lymphocytes expansion which is often associated with cytomegalovirus infec-
tion, idiopathic CD4+ T cell lymphopenia which presenting with extensive chick-
enpox and recurrent pneumonia, and early onset-autoimmunity [15]. The pleo-
morphic manifestations of RAG defi ciency result from hypomorphic mutations 
are explained by residual RAG protein activity [7]. To date, at least 76 distinct 
mutations have been described RAG1 gene [15]. Sometimes epigenetic factors 
including compound genetic defects, environmental factors, and infections effect 
on the clinical manifestation of RAG1 gene mutations and may alter phenotypical 
characteristics of the mutations of RAG1 gene. This indicates that unknown fac-
tors may play a role on the clinical picture of RAG1 mutations [12]. In the pre-
sented study, patient #4 presented with PG as atypical presentation. Also, in the 
presented patient #4, a novel homozygous mutation was defi ned in exon 2 of 
RAG1 gene (c.2290C > T).
In conclusion, herein, four patients and three distinct clinical spectrums 
associated with RAG1 mutations were presented. The fi rst and second patients 
had a typical classic T-B-NK+ SCID. The third patient was OS with the manifes-
tations of erythroderma, lymphadenopathies, eosinophilia, and increased serum 
IgE levels. The fourth one was atypical SCID with high levels of immunoglobu-
lins, low T cell, B cell and NK cell ratios, splenomegaly, PG, and autoimmunity. 
In the presented patients, the clinical and immunologic phenotypes were diverse 
as previously reported RAG1 mutations. In addition to classic SCID presentation 
in patients with atypical manifestation, as in the presented patient #4, it is impor-
tant to keep in mind the mutations of RAG1 genes.
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